project id: TCGA-UCEC; case submitter id: TCGA-BG-A0MK; analyte type: DNA; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.9; age at index: 52; days to birth: -19034; days to death: 1317; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1954; year of death: 2009; age at diagnosis: 19034; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1399; initial weight: 1100.0; sample id: 24678d73-94e1-49b4-a772-bda6a02d6075; sample submitter id: TCGA-BG-A0MK-01A; portion id: 079c2833-c221-4766-9eff-1761441a1427; portion submitter id: TCGA-BG-A0MK-01A-51; slide id: cedc4148-a29a-4a96-8862-6db908805e6c; slide submitter id: TCGA-BG-A0MK-01A-05-TS5; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 70.0; percent tumor nuclei: 60.0; section location: TOP;